Context and biological diversity
Persistent HPV infection contributes to the origin of a large proportion of cervical cancers, but detecting infection, a precursor lesion and invasive cancer are distinct situations. Histology, stage and screening history should be described. Population program results also depend on coverage, diagnostic confirmation and continuity of care.
What research makes it possible to study
TCGA’s integrated genomic analysis explored molecular alterations in cervical cancer and their relationship with tumor subgroups. These data support questions about mechanisms and diversity. Invasive cancer samples alone cannot estimate screening test performance or vaccination effects in a population.
Application in a research project
An implementation study can track the path from invitation to collection, result, confirmation and subsequent care. Each stage requires its own denominator, allowing losses to be located. Biomarker research should specify whether it targets viral persistence, a precursor lesion or invasive disease and use a suitable reference for that target.
Research questions
At which stages of a screening program is loss to follow-up greatest after an abnormal result?
- Study design
- An implementation cohort linking stages and analyzing region and access characteristics.
- What to measure
- Coverage, time to confirmation, the proportion followed up and inequalities between groups.
- Interpretation limits
- Increased detection does not demonstrate reduced mortality. Implementation findings depend on the health system and access to care after testing.
Interpretation limits
Increased detection does not demonstrate reduced mortality. Implementation findings depend on the health system and access to care after testing.
Original references
Continue exploring
Research questions
Educational content for framing research. Consult the original document, study population and methodology before interpreting a conclusion. Methodology